Fibroblast therapy helps restore myelin in 2 mouse models of MS
Fibrobiologics’ investigational cell therapy CYMS101Â can significantly increase myelin production and promote myelin repair in a mouse model of multiple sclerosis (MS), the company has announced. The experimental therapy, which is made of connective tissue cells called fibroblasts, demonstrated benefits within seven weeks after both single and multiple infusions…